New study aims to cut opioid use after chest surgery
NCT ID NCT07437027
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compares two types of nerve blocks—erector spinae plane block and thoracic paravertebral block—for pain control after chest surgery. About 86 adults undergoing open chest surgery will receive one of the blocks with a numbing medicine (bupivacaine) to see which reduces the need for morphine in the first 24 hours. The goal is to find a better way to manage pain while using fewer opioids.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- bupivacaine
- What this could lead to
- If successful, this could show that one nerve block provides better pain relief with less morphine after chest surgery.
- What could go wrong
- This is a small, early-stage study with only 86 participants, so results may not apply to everyone. The blocks may not differ significantly in pain control.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POST-THORACOTOMY PAIN are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Kasr al aini hospital
Cairo, Kasr Alaini, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.